SPH7854 granules in healthy volunteers
Part of Digestive system clinical trials.
This early-phase trial tests a new drug called SPH7854 granules in healthy people to check how the body processes it and if it's safe. You would take the drug and have regular check-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult
- You are willing to use effective birth control during the study and for a period after
- You do not plan to donate sperm or eggs
- You are not pregnant or breastfeeding
- You do not have serious allergies or allergic diseases
- You have not taken any forbidden drugs or foods before the first dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This trial tests a new medicine called SPH9788 in healthy people to see how the body handles it. Volunteers must be generally healthy and follow lifestyle rules to help researchers understand the drug's safety and effects.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
This trial tests a new medicine to see if it's safe for people with moderate to severe ulcerative colitis. It also tests the medicine in healthy volunteers to check for side effects. If you have ulcerative colitis, this might offer a new treatment option.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.